Loading clinical trials...

COPE With COPD Trial | Clinical Trials | Clareo Health

COMPLETEDNA

COPE With COPD Trial

Collaborative Self-Management Patient Education Will Improve Health Outcomes in COPD

NCT02343055•London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

Summary

The overall objective of this study is to evaluate a collaborative self-management intervention in patients with moderate to severe COPD in a primary care population. To achieve this objective the investigators developed a diagnostic and treatment pathway for the management of COPD in primary care that is based on national guidelines and focused on patient self-management. .

Eligibility

Age

40 - No limit years

Sex

ALL

Healthy Volunteers

Inclusion Criteria

•Current or Ex-smokers
•40 years of age or over
•Minimum 10 pack year smoking history
•Post-bronchodilator FEV1 of 70% or less (4 puffs of Salbutamol) and Forced Expiratory Volume at 1sec to Forced Vital Capacity (FEV1/FVC) ratio 70% or less
•A history of two exacerbations (involving treatment and/or visit to a health care practitioner) in the past 3 years OR 1 exacerbation in the past year
•Provides informed consent

Exclusion Criteria

•COPD exacerbation in the past 4 weeks
•Diagnosis of asthma prior to the age of 40 years
•Co-existing illness that could interfere with study results (ie. Congestive Heart Failure with exacerbation of symptoms)
•Scheduled for COPD rehabilitation
•A terminal illness

Locations (4)

Amherstburg FHT

Amherstburg, Ontario, Canada

Chatham-Kent FHT

Chatham, Ontario, Canada

Harrow FHT

Harrow, Ontario, Canada

Leamington FHT

Leamington, Ontario, Canada

Key Dates

Start Date

October 1, 2011

Primary Completion Date

January 1, 2015

Completion Date

January 1, 2015

Last Updated

July 30, 2018

Enrollment

182

ACTUAL participants

Conditions

Chronic Obstructive Pulmonary Disease

Interventions

Case Management and Self-Management Education

OTHER

cfMSC Stem Cell Therapy Targeting COPD

NCT07477600

Chronic Obstructive Pulmonary Disease (COPD)

View study

RECRUITINGPHASE3

A Study to Evaluate the Long-Term Safety of Astegolimab in Participants With Chronic Obstructive Pulmonary Disease (COPD)

NCT05878769

Chronic Obstructive Pulmonary Disease

View study

RECRUITINGNA

Probiotics in Pulmonaty Rehabilitation for COPD

NCT06717659

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: July 30, 2018Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

COPE With COPD Trial

Inclusion Criteria

Exclusion Criteria

cfMSC Stem Cell Therapy Targeting COPD

A Study to Evaluate the Long-Term Safety of Astegolimab in Participants With Chronic Obstructive Pulmonary Disease (COPD)

Probiotics in Pulmonaty Rehabilitation for COPD

A Cohort for Inflammatory Respiratory Diseases: From Phenotyping to Personalised Medicine

Breathe Easier With Tadalafil Therapy for Dyspnea in COPD-PH

A Clinical Study of Inhaled Nitric Oxide in Patients With Chronic Obstructive Pulmonary Disease